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Introduction {#sec1}
============

The 3′ poly(A) tail of eukaryotic mRNAs is a central determinant of gene expression. The conserved cytoplasmic poly(A)-binding protein (Pab1 in yeast/PABPC1 in mammals) binds to the poly(A) tail with high affinity. Pab1/PABPC1 interacts with translation initiation factors to promote mRNA translation and also protects mRNAs from degradation ([@bib9], [@bib14], [@bib40]). Consistent with this, shortening of the poly(A) tail (deadenylation) and release of Pab1 repress gene expression by reducing translation and mRNA stability. Deadenylation can be stimulated by miRNAs, mRNA-binding proteins, and covalent RNA modifications. Despite the central role of deadenylation in gene expression, it is unclear how exonucleases gain access to a poly(A) tail that is concealed by tightly bound Pab1.

Deadenylation is catalyzed by Ccr4-Not and Pan2-Pan3 ([@bib50], [@bib53]). Ccr4-Not, which is thought to play the major role, contains seven core subunits, including two poly(A)-selective exonucleases, Ccr4 and Caf1/Pop2 ([@bib35]). Ccr4-Not is recruited to specific mRNAs to direct rapid deadenylation during diverse biological processes, including embryogenesis, immunological responses, and cell proliferation ([@bib6], [@bib10], [@bib45]). Targeted deadenylation occurs when proteins bound to specific mRNA sequences recruit the Ccr4-Not complex ([@bib20], [@bib44], [@bib53]). The action of these mRNA-binding proteins does not, however, fully account for the wide range of half-lives observed across the eukaryotic transcriptome ([@bib11]). An additional major determinant of mRNA decay is the rate of translation elongation, and this correlates with codon optimality ([@bib37]). The coupling between translation and mRNA stability depends on the DEAD-box helicase Dhh1/DDX6 ([@bib38]) and is linked to deadenylation ([@bib4], [@bib31], [@bib37]). Yet, the molecular mechanisms whereby the RNA decay machinery senses translation rates remain largely enigmatic.

The two nucleases of Ccr4-Not have similar enzymatic activities *in vitro* and overlapping roles in deadenylation *in vivo*. Purified human, mouse, and yeast Ccr4 and Caf1 are poly(A)-specific nucleases ([@bib7], [@bib16], [@bib47], [@bib51], [@bib52], [@bib54]). We recently demonstrated that both nucleases are active when they are integrated into an intact recombinant *Schizosaccharomyces pombe* (*S. pombe*) Ccr4-Not complex, and active site mutations in either nuclease have only minor effects on the overall activity ([@bib44]). Deletion of Ccr4 in *Saccharomyces cerevisiae* (*S. cerevisiae*) does, however, impair rates of poly(A) tail shortening more than deletion of Caf1 ([@bib50]). Furthermore, the nucleases are structurally dissimilar: Ccr4 is a member of the endonuclease-exonuclease-phosphatase (EEP) family, while Caf1 adopts an RNase D fold. It is therefore unclear whether the nucleases of Ccr4-Not have separable enzymatic functions and whether they are differentially regulated by additional factors.

Pab1/PABPC1 contains four RNA recognition motif (RRM) domains that together bind poly(A) RNA with low nanomolar affinity ([@bib24]). A C-terminal region, comprised of a proline-rich linker (P-linker) and C-terminal domain (CTD), mediates self-association and interactions with other proteins ([@bib30]). RRMs 1 and 2 are thought to bind with higher affinity and be more specific for poly(A) than RRMs 3 and 4 ([@bib8], [@bib24]).

A current model suggests that a conserved role of Pab1/PABPC1 is to conceal the 3′ end of mRNAs, protecting them from Ccr4-Not ([@bib27], [@bib35], [@bib58]). Consistent with this, excess Pab1 was reported to inhibit the activity of purified *S. cerevisiae* Ccr4 and Caf1 using *in vitro* assays ([@bib43], [@bib51], [@bib52]). It is therefore possible that other proteins release Pab1 to permit deadenylation ([@bib22], [@bib56], [@bib60]). Recent data showing that PABPC1 occupancy on mRNAs is not correlated with steady-state poly(A) tail lengths may support this model ([@bib39], [@bib60]). Contrary to the view of Pab1 as an inhibitor of deadenylation, Pab1-deficient yeast have a reduced rate of poly(A) shortening ([@bib9]). Furthermore, PABPC1 was required for efficient miRNA-induced deadenylation in a mouse cell extract system ([@bib18]). Since Pab1/PABPC1 is an essential gene with pleiotropic functions, studying its role in deadenylation *in vivo* is a particular challenge.

Here, we use a fully reconstituted biochemical system to investigate the activity of *S. pombe* Ccr4-Not on Pab1-bound RNA and elucidate how Pab1 is released. Surprisingly, Pab1 differentiates the activities of the two Ccr4-Not nucleases: only Ccr4 is capable of shortening poly(A) tails bound by Pab1. *In vivo*, we find that *S. cerevisiae* transcripts with optimal codons have higher Pab1 occupancy, undergo slow poly(A) tail removal, and are not dependent on Caf1 for deadenylation. Collectively, our findings reveal a functional distinction between the deadenylase enzymes of Ccr4-Not and provide mechanistic insight into the coupling between translation, mRNP (messenger ribonucleoprotein) complex composition, and mRNA stability.

Results {#sec2}
=======

Pab1 Accelerates Shortening of the Poly(A) Tail by Ccr4-Not {#sec2.1}
-----------------------------------------------------------

To study the effect of Pab1 on Ccr4-Not activity and to determine how Pab1 is released from mRNAs, we reconstituted this process *in vitro*. Recombinant *S. pombe* Ccr4-Not complex was isolated from insect cells overexpressing all seven core subunits ([@bib44]) ([Figure S1](#mmc1){ref-type="supplementary-material"}A). To approximate physiological conditions, we used a model RNA substrate with a short upstream "3′ UTR" sequence followed by 60 adenosines (20-mer-A60) ([@bib55]). We loaded purified Pab1 onto this RNA with controlled stoichiometry (two Pab1 molecules/RNA) and verified this using electrophoretic mobility shift assays ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C). When purified Ccr4-Not was incubated with the model RNA substrate, the poly(A) tail was removed ([Figure 1](#fig1){ref-type="fig"}A). Surprisingly, the average deadenylation rate was increased 3-fold when Pab1 was present ([Figure S1](#mmc1){ref-type="supplementary-material"}D). Thus, the activity of Ccr4-Not is not restricted by Pab1 binding tightly to the poly(A) RNA substrate.Figure 1Pab1 Stimulates Stepwise Deadenylation by Ccr4-Not(A) Deadenylation by purified Ccr4-Not in the presence and absence of Pab1. The RNA substrate comprises 20 non-poly(A) nucleotides followed by a 60-adenosine poly(A) tail. RNA products (4-min time points) were resolved on a denaturing polyacrylamide gel. Pab1-bound substrates were prepared with two Pab1 molecules per RNA.(B) Coomassie-stained SDS-PAGE of pull-down assay showing binding of purified Ccr4-Not (red labels) to immobilized GST-Pab1. Purified proteins (before mixing), Input (proteins mixed before loading on resin), and Pull-down (proteins bound to resin after washing) are shown. The asterisk indicates a contaminant protein.(C) Deadenylation of 5′ fluorescently labeled 23-mer-A30 RNA substrate. Pab1-bound substrates were prepared with one Pab1 molecule per RNA. Poly(A) tail lengths are indicated, and RRM footprints are marked with red asterisks.(D) Deadenylation of 5′ fluorescently labeled 23-mer-A30 RNA substrates in the presence of Pab1 variants. The positions of footprints observed with wild-type Pab1 in (C) are indicated with red asterisks.See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

One mechanism whereby Pab1 could increase the rate of deadenylation is by direct interaction with the Ccr4-Not complex, recruiting it to the RNA substrate. To test this, we used pull-down assays and found that purified Ccr4-Not bound to immobilized GST-Pab1 ([Figure 1](#fig1){ref-type="fig"}B). Thus, the rate of deadenylation by Ccr4-Not is likely accelerated by Pab1 due to a direct physical interaction between these factors.

Previous reports that Pab1 inhibits deadenylation by isolated Ccr4 ([@bib50]) led to the prevailing view that Pab1 protects against the removal of the poly(A) tail. In those experiments, however, Pab1 was present in a 4- to 400-fold molar excess over RNA. Consistent with this, we found that addition of excess Pab1 inhibited deadenylation by Ccr4-Not approximately 2-fold ([Figure S1](#mmc1){ref-type="supplementary-material"}E). Excess Pab1 did not inhibit deadenylation of a substrate lacking an upstream sequence ([Figure S1](#mmc1){ref-type="supplementary-material"}E). Thus, excess Pab1 likely bound to the non-poly(A) sequence upstream of the poly(A) tail ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Together, these data show that excess Pab1 can slow deadenylation when the RNA substrate contains a 3′ UTR, and it does not inhibit deadenylation by concealing the poly(A) tail. Instead, when it is stoichiometrically loaded onto poly(A) tails, Pab1 can promote removal of A60 tails, likely through a direct interaction with Ccr4-Not.

Deadenylation Reveals the 3′ Ends of Pab1 RRM Footprints {#sec2.2}
--------------------------------------------------------

Deadenylation in the presence of Pab1 was not uniform along the length of the poly(A) tail and appeared to proceed in a series of steps ([Figure 1](#fig1){ref-type="fig"}A). To analyze this at higher, single-nucleotide resolution, we used an RNA substrate with a 30-adenosine tail that bound one Pab1 molecule. Pab1 did not largely affect the average rate at which the 30-adenosine tail was shortened, but it caused the accumulation of three different RNA species, separated in size by ∼8 nucleotides (A8, A16, and A24) ([Figures 1](#fig1){ref-type="fig"}C, [S1](#mmc1){ref-type="supplementary-material"}D, and [S2](#mmc1){ref-type="supplementary-material"}A). Hence, Pab1 causes deadenylation to proceed stepwise, pausing at defined and regularly spaced intervals.

We hypothesized that the steps in deadenylation are caused by protection of the poly(A) tail by the RRM domains of Pab1. The position of the steps would therefore represent the 3′ end of an RRM domain footprint on RNA, defined by the binding site of the RRM and steric constraints imposed by the colliding nuclease and Pab1. Consistent with this, deadenylation also proceeded in ∼8 nucleotide steps in the presence of a truncated Pab1 protein containing only the four RRMs ([Figures S2](#mmc1){ref-type="supplementary-material"}B--S2D).

To understand the contribution of each RRM, we generated four Pab1 variants, each with a mutation that impairs the binding of RNA to one RRM domain ([@bib17]). A mutation that impairs RNA binding to RRM 4 had no effect on the deadenylation activity of Ccr4-Not ([Figure 1](#fig1){ref-type="fig"}D). Mutation in RRM 2 had a moderate effect, reducing the prominence of the footprints. In contrast, mutation of RRM 1 or 3 produced more substantial changes in the pattern of footprints, reducing the stepwise nature of deadenylation ([Figure S2](#mmc1){ref-type="supplementary-material"}E). It is likely that mutation of one RRM influences RNA binding by adjacent RRMs, thereby leading to these complex effects on deadenylation. Based on these results, we propose that in wild-type Pab1, RRMs 1, 2, and 3 each protect ∼8 nucleotides of the poly(A) tail, and Ccr4-Not stalls when it encounters each one.

Previous studies had shown that RRM 4 is not selective for poly(A) ([@bib8]). Given that we do not observe a footprint for RRM 4 in deadenylation reactions ([Figure 1](#fig1){ref-type="fig"}D), this domain may be bound to the non-poly(A) 3′ UTR of the RNA rather than the poly(A) tail. The Pab1 molecule at the 5′ end of the poly(A) tail may therefore bind across the junction of the 3′ UTR and poly(A). This model is consistent with transcriptome-wide mapping of Pab1 binding sites in yeast, which showed that Pab1 binds non-poly(A) sequences and that RRM 4 is the primary site of protein-RNA crosslinks ([@bib1], [@bib23], [@bib49]). This also suggests the possibility that the 3′ UTR sequence could further influence Pab1 positioning.

Shortening of the Pab1-Bound Poly(A) Tail Is Catalyzed by Ccr4, but Not Caf1 {#sec2.3}
----------------------------------------------------------------------------

We recently showed that both nucleases in Ccr4-Not mediate *in vitro* deadenylation of a model RNA ([@bib44]). To investigate whether the activities of Ccr4 and Caf1 are similarly redundant on Pab1-bound RNAs, we used purified Ccr4-Not variants with point mutations that abolish the catalytic activity of either nuclease ([Figure S2](#mmc1){ref-type="supplementary-material"}F). Caf1 inactivation did not change *in vitro* deadenylation by Ccr4-Not ([Figure 2](#fig2){ref-type="fig"}A). In contrast, in the presence of Pab1, a complex containing inactive Ccr4 did not fully deadenylate substrate RNAs with a 30-adenosine tail ([Figure 2](#fig2){ref-type="fig"}A). A product with ∼22 adenosines accumulated but only in the presence of Pab1. Thus, surprisingly, removal of the Pab1-bound poly(A) tail required the catalytic activity of Ccr4, but not that of Caf1. The 22 nucleotides resistant to deadenylation likely represent the footprint of Pab1 on poly(A) RNA.Figure 2Shortening of Pab1-Bound Poly(A) Tails Is Catalyzed by Ccr4(A) Deadenylation of a 23-mer-A30 RNA in the absence or presence of Pab1 by Ccr4-Not and variant complexes with mutations in the active site of Ccr4 (Ccr4-inactive), Caf1 (Caf1-inactive), or both Ccr4 and Caf1 (double-inactive). Densitometric analyses were performed on selected gels (bottom).(B) Global poly(A) tail length in wild-type (WT) *S. cerevisiae* and strains containing deletion of *CCR4* or *CAF1*. The red asterisk indicates incomplete deadenylation in the *ccr4*Δ strain. Densitometric analyses were performed on selected gels (bottom).(C) Deadenylation of a 23-mer-A30 RNA by isolated Caf1 protein, Ccr4 (EEP nuclease domain), or the Caf1-Ccr4 heterodimer.(D) Coomassie-stained SDS-PAGE of pull-down assays showing binding of purified Ccr4 or Caf1 to immobilized GST-Pab1. Contaminant proteins are indicated with asterisks.In (A) and (C), Pab1-bound substrate was prepared with one Pab1 molecule per RNA. See also [Figures S2](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"}.

To test whether Ccr4 or Caf1 is required for removal of the Pab1-bound poly(A) tail *in vivo*, we examined global poly(A) tail shortening following transcriptional shut-off in *S. cerevisiae* strains containing a deletion of either *CCR4* or *CAF1*. Whereas wild-type yeast showed a continuous range of poly(A) tail lengths that shorten with time, the *ccr4*Δ strain accumulated poly(A) tails of ∼30 adenosines and had a marked reduction of poly(A) tails shorter than ∼22 adenosines ([Figure 2](#fig2){ref-type="fig"}B). Based on the similarity in the size of this protected region to that observed with the Ccr4 mutant complex *in vitro*, this likely represents a footprint of Pab1 *in vivo*. Deletion of *CAF1* did not generate a similar footprint ([Figure 2](#fig2){ref-type="fig"}B).

Pab1 Stimulates Isolated Ccr4 but Inhibits Isolated Caf1 {#sec2.4}
--------------------------------------------------------

We tested whether the requirement for Ccr4 to deadenylate Pab1-bound poly(A) tails is a property of the intact Ccr4-Not complex or intrinsic to the nuclease subunits. Purified, isolated nucleases were \>10-fold less active than the Ccr4-Not complex, necessitating the use of higher protein concentrations in the assays. Pab1 inhibited the activity of purified Caf1, reducing the average rate of deadenylation by 3-fold ([Figure 2](#fig2){ref-type="fig"}C). Importantly, however, deadenylation by Caf1 was not halted at ∼22 adenosines like Ccr4-inactive Ccr4-Not. This indicates that additional subunits of the Ccr4-Not complex regulate the activity of Caf1 and enforce the dependence on Ccr4 for the removal of adenosines bound by Pab1.

In contrast, the activity of the isolated nuclease domain of Ccr4 was strongly stimulated by the presence of Pab1 ([Figures 2](#fig2){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}G). Pab1 also stimulated a heterodimeric complex consisting of only Caf1 and Ccr4, and Ccr4 activity was required for this effect ([Figures 2](#fig2){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}H). Hence, the overall effect of Pab1 on each deadenylase enzyme is similar whether they are isolated or integrated into the intact Ccr4-Not complex. However, the activity of Caf1 is more restricted when it is part of Ccr4-Not, indicating that non-enzymatic subunits of the complex play a regulatory role.

Ccr4 Interacts with Pab1 {#sec2.5}
------------------------

Since Pab1 influences the activities of the isolated nucleases of Ccr4-Not, we tested whether Pab1 interacts directly with Ccr4 and Caf1. In pull-down assays, GST-Pab1 interacted weakly but reproducibly with the nuclease domain of Ccr4, but not with Caf1 ([Figures 2](#fig2){ref-type="fig"}D and [S3](#mmc1){ref-type="supplementary-material"}A). This likely accounts for the stimulation of isolated Ccr4 activity by Pab1.

The C-terminal portion of Pab1 comprising the proline-rich linker and the CTD was important for interaction with Ccr4 and its stimulatory effect on deadenylation ([Figures S3](#mmc1){ref-type="supplementary-material"}B--S3E). Still, Ccr4 activity was required for Ccr4-Not-mediated release of Pab1 lacking the P-linker and CTD ([Figure S3](#mmc1){ref-type="supplementary-material"}F).

Ccr4-Inactive Ccr4-Not Reveals the Organization of Pab1 on the Poly(A) Tail {#sec2.6}
---------------------------------------------------------------------------

Since the Caf1 exonuclease in Ccr4-inactive complex stops when it encounters nucleotides bound by Pab1, we could use this complex to map the Pab1 binding site on RNAs. An RNA containing 30 adenosines (lacking the upstream 3′ UTR sequence) was not efficiently deadenylated by Ccr4-inactive complex ([Figure 3](#fig3){ref-type="fig"}A). This is consistent with the ∼27-nucleotide footprint of Pab1 observed when cellular mRNA poly(A) tails were digested with RNase T2 ([@bib2]). In contrast, the footprint of Pab1 on the poly(A) tail of an RNA with an upstream 3′ UTR is ∼22 nucleotides ([Figure 3](#fig3){ref-type="fig"}A). Hence, the 3′ UTR alters the position of Pab1 binding to an A30 sequence, allowing more adenosines to be enzymatically removed by Caf1. This finding supports our model in which Pab1 RRMs 1--3 bind selectively to poly(A), while RRM 4 instead binds to the 3′ UTR. Pab1 molecules that do not have access to a 3′ UTR bind poly(A) with all four RRMs and consequently generate a longer poly(A) footprint.Figure 3Pab1 Organization on the Poly(A) Tail(A) Deadenylation by Ccr4-inactive Ccr4-Not to map Pab1-binding site on A30 and 23-mer-A30 RNA substrates. Red asterisks indicate accumulated product poly(A) tail lengths.(B) Deadenylation reaction end points (180 min) following addition of Ccr4-inactive Ccr4-Not to A30 (top) and 23-mer-A30 (bottom) RNA substrates in the presence of the indicated Pab1 variants. Red asterisks indicate accumulated product poly(A) tail lengths. Full time courses are shown in [Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B. Models of Pab1 binding to each RNA are shown on the right.(C) Deadenylation by Ccr4-inactive Ccr4-Not on 20-mer-A60 RNA in the absence or presence of Pab1 (2:1 molar ratio to RNA). Densitometric analysis of the reaction with Pab1 shows that the protected RNA fragment is ∼50--55 adenosines. A model for Pab1-RNA binding is shown.See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

Experiments with Pab1 variants containing mutations in each RRM domain provided further support for this model: RRM 4 mutation resulted in a reduction of the size of the protected sequence from 28 to 22 nucleotides on the A30 RNA but had no effect on a substrate with an upstream 3′ UTR sequence ([Figures 3](#fig3){ref-type="fig"}B and [S4](#mmc1){ref-type="supplementary-material"}A). The size of the footprint on the substrate with an upstream 3′ UTR was instead reduced from 22 to 16 adenosines by a mutation in RRM 3 ([Figures 3](#fig3){ref-type="fig"}B and [S4](#mmc1){ref-type="supplementary-material"}B).

Two Pab1 molecules on a 60-adenosine substrate protect 50--55 adenosines ([Figure 3](#fig3){ref-type="fig"}C). This corresponds to the sequence protected by RRMs 1--3 of a Pab1 molecule that is bound proximal to the 3′ UTR (∼22 nucleotides) plus the sequence that is protected if all four RRMs bind poly(A) (∼28 nucleotides; [Figure 3](#fig3){ref-type="fig"}C). We note that the arrangement of Pab1 on RNA, with RRM 4 bound to the 3′ UTR, may not exist prior to the onset of deadenylation: both molecules of Pab1 could initially bind poly(A) with all four RRM domains, but as the tail is shortened, the UTR-proximal molecule is forced into the non-poly(A) region.

The 3′ UTR Can Stabilize Pab1 Binding {#sec2.7}
-------------------------------------

Pab1 release from RNA is important for control of translation and RNA stability *in vivo*. Because Ccr4-Not deadenylates Pab1-bound poly(A) tails, it can release Pab1, yet it is not known how many nucleotides must be removed before this occurs. It was previously reported that the shortest poly(A) sequence that Pab1 binds with high affinity is ∼12 nucleotides ([@bib24], [@bib41]). In our experiments, the accumulation of RNA products with tail lengths of ∼8 adenosines indicated that Pab1 influences deadenylation even when the poly(A) tail is shortened to this length ([Figure 1](#fig1){ref-type="fig"}). Consistent with this, Pab1 generated a prominent 8-nt deadenylation footprint when a model mRNA with a short, 10-adenosine tail was used as a substrate ([Figure S4](#mmc1){ref-type="supplementary-material"}C).

To investigate whether Pab1 binding to the poly(A) tail can be stabilized through interactions with upstream 3′ UTR sequences, we compared the affinities of Pab1 for A12 RNAs with and without a 10-nt non-poly(A) upstream sequence. Using fluorescence polarization assays, we found that Pab1 binds the 10-mer-A12 RNA with substantially higher affinity than A12 alone (*K*~D~ ∼2.0 nM and ∼27 nM, respectively; [Figure 4](#fig4){ref-type="fig"}A). Pab1 binds an A22 RNA with even higher affinity (*K*~D~ ∼0.5 nM). Hence, the interaction of Pab1 with short poly(A) RNA is stabilized by an upstream non-poly(A) sequence.Figure 4Ccr4-Not Releases Pab1 from Short Poly(A) Tails(A) Fluorescence polarization assay showing interaction of Pab1 with 5′ 6-FAM-labeled A22, 10-mer-A12, and A12 RNAs. Error bars are standard error (n = 3 for A12; n = 5 for A22 and 10-mer-A12). *K*~D~s are represented as the mean ± standard error.(B) Deadenylation of A30 and 23-mer-A30 RNAs by Ccr4-Not analyzed by both denaturing PAGE (upper gels) and native PAGE (lower gels). Samples were collected from the same reaction at the indicated time points after addition of Ccr4-Not to allow a direct comparison between RNA product sizes and Pab1 binding, respectively. Pab1-bound substrate was prepared with one Pab1 molecule per RNA. Upper right panel is reproduced from [Figure 1](#fig1){ref-type="fig"}C for comparison.(C) Representative SwitchSENSE sensograms showing the dissociation of Pab1 from the indicated RNA sequences. Rate constants and half-lives for dissociation with standard error are shown for measurements performed in triplicate.See also [Figures S4--S6](#mmc1){ref-type="supplementary-material"}.

Ccr4-Not Does Not Release Pab1 until the Poly(A) Tail Is \<10 Nucleotides {#sec2.8}
-------------------------------------------------------------------------

To measure the dissociation of Pab1 during poly(A) removal, we stopped the magnesium-dependent deadenylation reaction at a series of time points with EDTA and separated Pab1-bound RNA from unbound RNA by native gel electrophoresis. Pab1 dissociated from RNA without an upstream 3′ UTR sequence when the tail was shortened to ∼20 adenosines ([Figure 4](#fig4){ref-type="fig"}B, left). In contrast, Pab1 remained stably associated with the UTR-containing RNA until the final ∼8 adenosines were removed ([Figure 4](#fig4){ref-type="fig"}B, right). The 3′ UTR sequence therefore affects deadenylation by anchoring Pab1 to the proximal region of the poly(A) tail, stabilizing its binding even when the poly(A) tail is less than 10 adenosines.

We sought to understand the kinetics of Pab1 dissociation using SwitchSENSE ([Figure 4](#fig4){ref-type="fig"}C). In this technique, fluorescently labeled DNA nanolevers hybridized to an RNA of interest are oscillated by an alternating electric field. The speed at which the nanolevers respond to the changing electric potential is reduced upon binding of protein ([@bib12]). By monitoring this in real time, we measured the dissociation rates of Pab1 from RNAs with a 3′ UTR and poly(A) tails of 5, 10, or 15 adenosines. The *k*~*off*~ was over an order of magnitude faster on an RNA substrate with a 5-adenosine tail compared to a 10-adenosine tail. This agrees with Pab1 binding to RNA during deadenylation assays ([Figure 4](#fig4){ref-type="fig"}B) and is consistent with Pab1 dissociating from mRNAs when the poly(A) tail is shortened to 5--10 adenosines. As a single RRM footprints ∼8 adenosines, it is likely that Pab1 release generally occurs once the poly(A) tail has been shortened beyond this length.

The overall binding affinity (*K*~D~) of Pab1 for 30-adenosine RNA was ∼0.2 nM ([Figure S5](#mmc1){ref-type="supplementary-material"}). The half-life for dissociation is approximately 40 min ([Figure 4](#fig4){ref-type="fig"}C). In contrast, the Pab1-bound poly(A) tail can be removed in under 5 min in conditions of excess Ccr4-Not ([Figure S6](#mmc1){ref-type="supplementary-material"}). Thus, dissociation of Pab1 from the poly(A) tail does not appear to be inherently rate limiting to deadenylation *in vitro*. Instead, the exonuclease activity of Ccr4-Not releases Pab1 by shortening the poly(A) sequence to which Pab1 binds.

Codon Optimality Is Correlated with Pab1 Association with mRNA {#sec2.9}
--------------------------------------------------------------

Pab1 is thought to be associated with the mRNAs of all genes, but recent data suggest that Pab1 occupancy varies in a gene-dependent manner ([@bib15]). For example, Pab1 is enriched on mRNAs encoding ribosomal proteins and on transcripts with high ribosome occupancy. This is particularly striking because short poly(A) tails are a general feature of highly expressed transcripts ([@bib29]). Since highly expressed transcripts often have more optimal codons, we hypothesized that codon usage may correlate with Pab1 occupancy and have consequences on deadenylation.

To examine this, we analyzed data from a recently published Pab1 RNA-immunoprecipitation experiment ([@bib15]). We binned mRNAs by codon optimality and asked whether there were differences in Pab1 binding per length of poly(A) tail ([@bib45]). Strikingly, we observed that when normalized to overall mRNA poly(A) tail length, mRNAs of high codon optimality had enhanced Pab1 association compared to those of low codon optimality ([Figure 5](#fig5){ref-type="fig"}A). These data reveal a distinction in mRNP composition that is correlated with codon optimality and thus with translational elongation rate.Figure 5Codon Optimality Influences Pab1 Association and mRNA Deadenylation Rate(A) Plot of Pab1-bound mRNA levels relative to total mRNA levels following normalization to poly(A) tail length and binning of mRNAs according to codon optimality. Values were calculated using previously published Pab1 RNA immunoprecipitation sequencing (RIP-seq), total RNA sequencing (RNA-seq), and poly(A) tail length profiling by sequencing (PAL-seq) data. ^∗∗∗^p~adj~ \< 10^−3^.(B) High-resolution polyacrylamide northern blots and plots of shortest poly(A) tail lengths of the OPT and NON-OPT mRNAs following *GAL1* transcriptional pulse-chase experiments in WT or *dhh1*Δ cells. A0 indicates the migration of a completely deadenylated mRNA species. Asterisk denotes the accumulation of deadenylated mRNA species. The lane labeled dT is the 0 time point treated with oligo dT and RNaseH to indicate the migration position of fully deadenylated mRNA. Representative gels and plots of experiments done in triplicate are shown.

Codon Optimality Influences mRNA Deadenylation Rate {#sec2.10}
---------------------------------------------------

Differences in Pab1 occupancy might contribute to altered patterns of deadenylation between optimal and non-optimal transcripts. To test this, we utilized reporter constructs encoding mRNA transcripts that are identical in UTR composition and encode the exact same polypeptide but represent extremes of overall codon optimality. The OPT mRNA contains only optimal codons, while the NON-OPT mRNA bears only non-optimal codons; this distinction causes them to degrade with a 4-fold difference in half-life ([@bib37]). Poly(A) tail lengths were visualized by northern blot after transcriptional pulse chase in *S. cerevisiae*.

In wild-type cells, the OPT mRNA was deadenylated more slowly than the NON-OPT mRNA, with oligo(A) species (\<A15) observed 30 min and 6 min, respectively, after inhibition of reporter transcription ([Figure 5](#fig5){ref-type="fig"}B). Deadenylation patterns are therefore sensitive to codon optimality.

We recently showed that the decapping activator Dhh1/DDX6 is critical to coupling low codon optimality to rapid mRNA decay ([@bib38]). To test whether differences in deadenylation of OPT and NON-OPT mRNAs depend on Dhh1, we compared deadenylation of the reporter RNAs in wild-type and *dhh1*Δ cells ([Figure 5](#fig5){ref-type="fig"}B). Deadenylation profiles were similar to wild-type, indicating that Dhh1 is not required for differences in deadenylation. The loss of Dhh1 function does, however, result in the accumulation of deadenylated mRNA that is likely stable because it does not undergo efficient decapping ([Figure 5](#fig5){ref-type="fig"}B, asterisk) ([@bib13]). These results show that codon optimality impacts deadenylation upstream and independent of Dhh1.

Codon Optimality Differentiates the Roles of Ccr4 and Caf1 in Deadenylation {#sec2.11}
---------------------------------------------------------------------------

Given that Pab1 occupancy is correlated with codon optimality and that Pab1 differentiates the two nucleases of Ccr4-Not, we analyzed the roles of Ccr4 and Caf1 in deadenylation of the reporter constructs with optimal and non-optimal codons after transcriptional shut-off *in vivo*. Deletion of *CCR4* stabilized both OPT and NON-OPT mRNAs (2.7-fold and 5.2-fold relative to WT, respectively; [Figure 6](#fig6){ref-type="fig"}A). This indicates that Ccr4 acts as a general deadenylase whose function in mRNA decay is independent of the influence of codon optimality. This is consistent with our finding that Ccr4 can remove poly(A) tails independent of whether Pab1 is bound.Figure 6Caf1 Destabilizes mRNAs with Low Codon Optimality by Accelerating Deadenylation Rate(A) Northern blots of the OPT and NON-OPT reporters following *GAL1* transcriptional shut-off experiments in WT, *ccr4*Δ, *caf1*Δ, and *dhh1*Δ yeast. mRNA half-lives are represented as mean ± standard deviation for experiments performed with four (*dhh1*Δ, *ccr4*Δ) or five (WT, *caf1*Δ) replicates.(B) Plots showing the deadenylation rate of the OPT and NON-OPT reporters in *rpb1-1*, *rpb1-1/ccr4*Δ, or *rpb1-1/caf1*Δ yeast determined from transcriptional pulse-chase experiments (see [Figure S7](#mmc1){ref-type="supplementary-material"}). Data points are represented as mean ± standard deviations for experiments performed in triplicate.(C) Northern blots of OPT and NON-OPT reporters in WT yeast and OPT and NON-OPT reporters containing a stem loop (SL) in the 5′ UTR (SL-mRNA) in WT, *ccr4*Δ, *caf1*Δ, or *dhh1*Δ yeast after *GAL1* transcriptional shut-off experiments.(D) Plot of *S. cerevisiae* mRNA half-lives in *caf1*Δ cells relative to WT cells binned according to codon optimality. ^∗∗^: 10^−2^ \> p~adj~ \> 10^−3^; ^∗∗∗^p~adj~ \< 10^−3^.See also [Figure S7](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}.

In contrast, deletion of *CAF1* increased the stability of NON-OPT mRNA (3.1-fold relative to WT) but did not substantially affect the stability of OPT mRNA ([Figure 6](#fig6){ref-type="fig"}A). Similar selectivity of Caf1, but not Ccr4, for non-optimal mRNAs was observed using a distinct set of reporters varying in codon optimality ([Figures S7](#mmc1){ref-type="supplementary-material"}A--S7C). These data indicate that Caf1 preferentially destabilizes non-optimal mRNAs. We propose that Pab1 enrichment on highly optimal mRNAs prevents Caf1 from contributing to their deadenylation, while lower levels of Pab1 on low-optimality mRNAs permits Caf1 function.

To determine whether Caf1-dependent decay of non-optimal mRNAs was due to more rapid deadenylation, we analyzed poly(A) tail lengths in pulse-chase experiments. The rapid deadenylation of NON-OPT mRNA in wild-type cells was abolished by deletion of *CAF1* ([Figures 6](#fig6){ref-type="fig"}B and [S7](#mmc1){ref-type="supplementary-material"}D; [Table S1](#mmc1){ref-type="supplementary-material"}). Importantly, the NON-OPT mRNA was deadenylated at a similar rate as the OPT mRNA in cells lacking *CAF1*. Therefore, Caf1 plays an important role in discriminating between optimal and non-optimal mRNAs by selectively accelerating deadenylation of non-optimal mRNAs.

Deletion of *CCR4* resulted in an ∼3.3- or 4.7-fold decrease of the deadenylation rate for both OPT and NON-OPT mRNAs, respectively ([Figure 6](#fig6){ref-type="fig"}B; [Table S1](#mmc1){ref-type="supplementary-material"}). This is consistent with its ability to remove all poly(A) tails independent of the presence of Pab1.

Caf1 Regulates mRNA Decay in a Translation-Dependent Manner {#sec2.12}
-----------------------------------------------------------

Preferential destabilization of non-optimal mRNAs by Caf1 is reminiscent of Dhh1 activity ([Figure 6](#fig6){ref-type="fig"}A). Since Dhh1 communicates translational elongation rate to mRNA decapping, its decay function requires mRNA translation ([@bib13]). To test whether the role of Caf1 in mRNA decay is also translation dependent, we introduced a stem-loop (SL) secondary structure into the 5′ UTR of reporter mRNAs (SL-OPT and SL-NON-OPT mRNAs) to inhibit translation. The SL structure has been shown to limit 48S ribosome scanning and reduce protein production to less than 10% ([@bib5], [@bib46]).

When translation of reporter mRNAs was blocked by the SL structure in WT cells, a difference in the half-lives of OPT and NON-OPT mRNAs was no longer observed ([Figure 6](#fig6){ref-type="fig"}C). This is consistent with our previous finding that translation is central to differential mRNA stability ([@bib37]).

We next performed transcriptional shut-off experiments on SL-containing OPT and NON-OPT mRNAs in cells lacking Caf1, Ccr4, or Dhh1. The SL-NON-OPT mRNA was not substantially stabilized in *caf1*Δ or *dhh1*Δ cells ([Figure 6](#fig6){ref-type="fig"}C). Furthermore, the half-lives of SL-OPT and SL-NON-OPT mRNAs are indistinguishable in these strains. In contrast, both SL-OPT and SL-NON-OPT mRNAs were stabilized in *ccr4*Δ cells ([Figure 6](#fig6){ref-type="fig"}C). This indicates that translation is not required for Ccr4 function. These results show that, like Dhh1, Caf1 discriminates between mRNAs of different codon optimality and regulates mRNA degradation in a translation-dependent manner, but Ccr4 is a general deadenylase affecting degradation of all mRNAs.

Loss of *CAF1* Broadly Stabilizes mRNAs of Low Codon Optimality {#sec2.13}
---------------------------------------------------------------

To determine whether Caf1 has a broad influence on the decay of mRNAs as a function of codon optimality, we conducted a genomic transcriptional shut-off experiment using a temperature-sensitive allele of RNA polymerase II (Pol II). Following heat inactivation of Pol II in *rpb1-1* and *rpb1-1/caf1*Δ strains, cells were harvested at various time points, and then global mRNA decay analysis was performed by RNA sequencing (RNA-seq) on libraries from each time point. We have used this approach successfully in the past and have shown that our data correlate well with mRNA half-lives achieved by other methods, such as metabolic labeling approaches ([@bib37]).

Using this approach, we obtained reproducible half-lives for 3,535 mRNAs in budding yeast. Binning mRNAs by codon optimality demonstrated that loss of *CAF1* generally stabilizes mRNAs of low codon optimality ([Figure 6](#fig6){ref-type="fig"}D). Taken together, our data suggest that deadenylation rate is enhanced on mRNAs of low codon optimality via the concerted efforts of Ccr4 and Caf1, while high-optimality transcripts are subject to only Ccr4-mediated deadenylation.

Discussion {#sec3}
==========

Deadenylation is a widespread process that regulates the translation and stability of eukaryotic mRNAs. While involvement of the Ccr4-Not complex and Pab1/PABPC1 in this process is well established, the way in which they directly affect each other and are influenced by other cellular signals has remained elusive. Here, we provide mechanistic insight into this process, showing that Pab1 does not block Ccr4-Not nuclease activity and that Pab1 can be efficiently released from RNAs by Ccr4, but not Caf1 ([Figure 7](#fig7){ref-type="fig"}A). The two nucleases are differentially active on low and high codon optimality transcripts. We propose that this is a result of differential Pab1 occupancy.Figure 7Models for Pab1 Release by Ccr4 and Coupling of Translation and Deadenylation Rates by Caf1(A) Proposed model for the organization of Pab1 on the poly(A) tail with RRMs depicted linearly. The Pab1 molecule proximal to the 3′ UTR binds ∼22 adenosines through RRMs 1−3, and distal Pab1 molecules bind ∼28 adenosines with RRMs 1--4. Naked poly(A) not bound by Pab1 can be removed by either Caf1 or Ccr4, while RNA within the binding site of Pab1 can only be accessed by Ccr4. Pab1 self-association and interaction with other proteins may lead to higher-order structures on RNA.(B) The modular architecture of Pab1 permits deadenylation to occur before it completely dissociates from the poly(A) tail.(C) Translation elongation rate may contribute to Pab1 occupancy to affect deadenylation rate. Ccr4 is required for deadenylation of all mRNAs, but the requirement for Caf1 is specific to mRNAs with low codon optimality or reduced Pab1 occupancy.

A Model for mRNA Deadenylation {#sec3.1}
------------------------------

Previous data suggested that Pan2-Pan3 may initiate deadenylation in cells whereas Ccr4-Not more efficiently removes shorter poly(A) tails ([@bib50], [@bib58]). This is consistent with a model of deadenylation in which these complexes act sequentially. It was proposed that the mechanistic basis for these two phases of deadenylation is binding of Pab1 to the poly(A) tail: Pan2-Pan3 is stimulated by Pab1 and would therefore remove the distal portion of the (Pab1-bound) poly(A) tail, while subsequent shortening of the proximal poly(A) tail by Ccr4-Not would only occur once Pab1 had been displaced ([@bib50], [@bib58]). Our data showing that Pab1 can be efficiently released *in vitro* by the exonuclease activity of Ccr4-Not suggest that Pab1 binding alone does not provide a mechanistic explanation for sequential deadenylation. In fact, deadenylation of Pab1-bound A60 RNAs by Ccr4-Not is faster than deadenylation on RNAs without Pab1.

*In vivo*, Ccr4 compensates for deletion of Pan2 ([@bib50]). In contrast, deadenylation does not proceed beyond ∼22 adenosines in the absence of Ccr4 ([Figure 2](#fig2){ref-type="fig"}B). This corresponds in size to the footprint of one Pab1 and suggests that Ccr4-Not, but not Pan2-Pan3, is able to efficiently release the final molecule of Pab1 from the poly(A) tail *in vivo*. Thus, our data are consistent with a model in which either complex can initiate deadenylation but only Ccr4-Not can remove the proximal part of the poly(A) tail.

Release of the final Pab1 precedes mRNA decapping and decay and is likely a critical point of regulation. Recent data suggest that highly expressed eukaryotic mRNAs often have short poly(A) tails (20--30 adenosines) ([@bib29]). Furthermore, translation efficiency in somatic cells decreases only when the poly(A) tail is shortened to less than 30 adenosines ([@bib34], [@bib45]). Combined, these data suggest that only one Pab1/PABPC1 molecule is required for efficient translation and high stability of mRNAs. We show here that the UTR-proximal Pab1 molecule binds RNA in a different manner to Pab1 on distal parts of the poly(A) tail: RRM 4 is not specific for poly(A), allowing the molecule to bridge the 3′ UTR:poly(A) tail junction. It is likely that Ccr4-Not plays a crucial role in releasing this final, 3′ UTR-proximal Pab1 molecule.

Mechanism of Pab1 Release {#sec3.2}
-------------------------

Deadenylation by Ccr4-Not proceeds in a stepwise pattern, likely because RRMs 1, 2, and 3 of Pab1 each protect ∼8 adenosines, and Ccr4-Not stalls when it encounters each RRM. If the terminal (3′) RRM disengages from the RNA (due to "breathing"), Ccr4-Not can remove terminal ribonucleotides, preventing the RRM from rebinding and resulting in tail shortening until another RRM is encountered ([Figure 7](#fig7){ref-type="fig"}B). This process is unidirectional, because once the tail is shortened, the RRM is unable to rebind. Each subsequent RRM is removed in the same manner. This could result in "peeling" of Pab1 off the RNA, one RRM at a time. Alternatively, Pab1 could slide or ratchet along the RNA: the 5′ proximal Pab1 molecule would move further into the 3′ UTR, allowing RRMs 1 and 2 to retain their high-affinity interactions with poly(A) RNA. The final Pab1 will be released once the tail is shorter than 8 nucleotides and no RRMs contact poly(A).

Each RRM domain of Pab1 binds RNA with low affinity ([@bib8], [@bib24], [@bib32]), but avidity effects increase overall affinity. Thus, the modular architecture of Pab1 allows shortening of the poly(A) tail without Pab1 completely dissociating from the mRNA. These are important properties for a protein that must remain stably bound to mRNA to promote translation and prevent decapping but that can also be rapidly released to promote translation repression and mRNA decay in response to cellular signals.

The Pab1-Bound Poly(A) Tail Is Shortened by Ccr4, but Not Caf1 {#sec3.3}
--------------------------------------------------------------

Although both Ccr4 and Caf1 are poly(A)-selective exonucleases, Pab1 differentiates their activities, and only Ccr4 is active on RNA bound by Pab1 ([Figure 7](#fig7){ref-type="fig"}A). Ccr4 is thought to be the major deadenylase in *S. cerevisiae* ([@bib47], [@bib50], [@bib51], [@bib3]). Based on our findings, this is likely due to the requirement for Ccr4 on Pab1-bound poly(A) tails.

Pab1 stimulates Ccr4 both in the Ccr4-Not complex and as an isolated protein, at least, in part, through direct contact with the EEP nuclease domain. Other mRNA-binding proteins interact with specific sequences in the 3′ UTR, and these are required for efficient deadenylation of specific transcripts. Compared to these other mRNA-binding proteins that recruit Ccr4-Not, the interaction between Pab1 and Ccr4-Not is likely lower affinity. By binding Pab1, Ccr4-Not may be able to efficiently locate the 3′ terminus of the mRNA to permit exonucleolytic activity.

Ccr4-Not and Pab1 Couple Translation with mRNA Decay {#sec3.4}
----------------------------------------------------

Our analysis reveals that the abundance or stability of Pab1 on the poly(A) tail correlates with the translation elongation rate set by codon optimality. Furthermore, Pab1 and the nucleases of Ccr4-Not provide a mechanistic link between the processes of mRNA decay and translation. Ccr4 shortens poly(A) independent of the presence of Pab1 and is a general deadenylase acting on all mRNAs. In contrast, Caf1 only shortens poly(A) that is not bound by Pab1 and is selective for non-optimal transcripts that are associated with lower Pab1 occupancy ([Figure 7](#fig7){ref-type="fig"}C). We previously reported that the decapping activator Dhh1/DDX6 is required for sensing and rapidly degrading mRNAs with low codon optimality. We show here that Caf1 is similarly essential to this process, acting upstream of Dhh1.

A critical and unresolved question is how translational elongation rates influence the overall mRNP architecture, including Pab1 binding, and how this makes transcripts differentially susceptible to deadenylases and Dhh1. There is a long-standing appreciation that translation rates and mRNA decay rates are tightly coupled. Our work provides a mechanistic understanding of the emerging concept that the mRNA degradation machinery is highly orchestrated to monitor the translatability of mRNAs.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Bacterial and Virus Strains***E. coli* BL21 star (DE3)Thermo Fisher ScientificC601003*E. coli* DH5α (DE3)Thermo Fisher Scientific18258012**Chemicals, Peptides, and Recombinant Proteins**Insect-XPRESS protein-free insect cell medium with L-glutamineLonza12-730QProtease Inhibitor CocktailSigma-Aldrich11836170001DesthiobiotinIBA2-1000-001ImidazoleSigma-AldrichI5513FormamideSigma-Aldrich11814320001TEMEDSigma-AldrichT9281Ammonium persulfate (APS)Sigma-AldrichA3678SYBR Safe DNA Gel StainThermo Fisher ScientificS33102SYBR Green II RNA Gel StainThermo Fisher ScientificS7586Ni-NTA AgaroseQIAGEN30210Glutathione Sepharose 4BGE Healthcare17075601Amicon Ultra Centrifugal Filter UnitsMilliporeUFC901096TWEEN 20Sigma-AldrichP9416*S. pombe* Ccr4-Not (WT) protein[@bib44]N/A*S. pombe* Ccr4-Not (Ccr4 E387A) protein[@bib44]N/A*S. pombe* Ccr4-Not (Caf1 D53A) protein[@bib44]N/A*S. pombe* Ccr4-Caf1 (WT) proteinThis paperN/A*S. pombe* Ccr4-Caf1 (Ccr4 E387A) proteinThis paperN/A*S. pombe* Ccr4-Caf1 (Caf1 D53A) proteinThis paperN/A*S. pombe* Ccr4 (EEP domain) proteinThis paperN/A*S. pombe* Caf1 proteinThis paperN/A*S. pombe* Pab1 proteinThis paperN/A*S. pombe* Pab1ΔC proteinThis paperN/A*S. pombe* Pab1ΔPC proteinThis paperN/A*S. pombe* Pab1 (Y83A) proteinThis paperN/A*S. pombe* Pab1 (F171A) proteinThis paperN/A*S. pombe* Pab1 (Y264A) proteinThis paperN/A*S. pombe* Pab1 (F367A) proteinThis paperN/A**Critical Commercial Assays**Quikchange Lightning Multi Site-Directed Mutagenesis KitAgilent Technologies210513In-Fusion HD Cloning KitTakara Bio121416Phusion High-Fidelity DNA PolymeraseNew England BioLabsM0530S**Deposited Data**Sequencing data for mRNA half-life analysisThis paperGEO: [GSE114560](ncbi-geo:GSE114560){#intref0010}Pab1 RIP-Seq[@bib15]13059_2014_559_MOESM2_ESM.xlsxPoly(A) tail lengths[@bib45]GSE52809_Cerevisiae_total.txt**Experimental Models: Organisms/Strains**yJC244[@bib33]MATa, *ura3-52*, *his3-200, leu2-3.112*, *rpb1-1*yJC1257This studyMATa, *ura3-52*, *his3-200*, *leu2-3.112*, *rpb1-1*, *caf1::HIS3*yJC1347This studyMATa, *ura3-52*, *his3-200*, *leu2-3.112*, *rpb1-1*, *ccr4::NEO*yJC1892[@bib37]MATa, ura3, leu2, his3, met15 \[pGAL-OPT-pG, URA3\]yJC1893[@bib37]MATa, ura3, leu2, his3, met15 \[pGAL-NON-OPT-pG, URA3\]yJC1961[@bib37]MATa, ura3, his3, leu2, met15, ccr4:NEO \[pGAL-OPT-pG, URA3\]yJC1962[@bib37]MATa, ura3, leu2, his3, met15, ccr4::NEO \[pGAL-NON-OPT-pG, URA3\]yJC1990This studyMATa, ura3, leu2, his3, met15, dhh1::NEO \[pGAL-OPT-pG, URA3\]yJC1991This studyMATa, ura3, leu2, his3, met15, dhh1::NEO \[pGAL-NON-OPT-pG, URA3\]yJC2318This studyMATa, ura3-52, his3-200, leu2-3.112, rpb1-1, ccr4::NEO \[pGAL-OPT-pG, URA3\]yJC2319This studyMATa, ura3-52, his3-200, leu2-3.112, rpb1-1, ccr4::NEO \[pGAL-NON-OPT-pG, URA3\]yJC2320This studyMATa, ura3-52, his3-200, leu2-3.112, rpb1-1 \[pGAL-OPT-pG, URA3\]yJC2321This studyMATa, ura3-52, his3-200, leu2-3.112, rpb1-1 \[pGAL-NON-OPT-pG, URA3\]yJC2324This studyMATa, ura3-52, his3-200, leu2-3.112, rpb1-1, caf1::HIS3 \[pGAL-OPT-pG, URA3\]yJC2325This studyMATa, ura3-52, his3-200, leu2-3.112, rpb1-1, caf1::HIS3 \[pGAL-NON-OPT-pG, URA3\]yJC2364This studyMATa, ura3, his3, leu2, met15, caf1::NEO \[pGAL-OPT-pG, URA3\]yJC2365This studyMATa, ura3, his3, leu2, met15, caf1::NEO \[pGAL-NON-OPT-pG, URA3\]yJC2499[@bib38]MATa, ura3, leu2, his3, met15 \[pGAL-optimal FLAG-0% HIS, URA3\]yJC2504[@bib38]MATa, ura3, leu2, his3, met15 \[pGAL-optimal FLAG-50% HIS, URA3\]yJC2509[@bib38]MATa, ura3, leu2, his3, met15 \[pGAL-optimal FLAG-100% HIS, URA3\]yJC2591This studyMATa, ura3, leu2, his3, met15 \[pGAL-SL-OPT-pG, URA3\]yJC2592This studyMATa, ura3, leu2, his3, met15 \[pGAL-SL-NON-OPT-pG, URA3\]yJC2658This studyMATa, ura3, his3, leu2, met15, ccr4::NEO \[pGAL-SL-OPT-pG, URA3\]yJC2659This studyMATa, ura3, his3, leu2, met15, ccr4::NEO \[pGAL-SL-NON-OPT-pG, URA3\]yJC2660This studyMATa, ura3, his3, leu2, met15, caf1::NEO \[pGAL-SL-OPT-pG, URA3\]yJC2661This studyMATa, ura3, his3, leu2, met15, caf1::NEO \[pGAL-SL-NON-OPT-pG, URA3\]yJC2666This studyMATa, ura3, leu2, his3, met15, dhh1::NEO \[pGAL-SL-OPT-pG, URA3\]yJC2667This studyMATa, ura3, leu2, his3, met15, dhh1::NEO \[pGAL-SL-NON-OPT-pG, URA3\]yJC2709This studyMATa, ura3, his3, leu2, met15, caf1::NEO \[pGAL-optimal FLAG-0% HIS, URA3\]yJC2710This studyMATa, ura3, his3, leu2, met15, caf1::NEO \[pGAL-optimal FLAG-50% HIS, URA3\]yJC2711This studyMATa, ura3, his3, leu2, met15, caf1::NEO \[pGAL-optimal FLAG-100% HIS, URA3\]yJC2724This studyMATa, ura3, his3, leu2, met15, ccr4::NEO \[pGAL-optimal FLAG-0% HIS, URA3\]yJC2725This studyMATa, ura3, his3, leu2, met15, ccr4::NEO \[pGAL-optimal FLAG-50% HIS, URA3\]yJC2726This studyMATa, ura3, his3, leu2, met15, ccr4::NEO \[pGAL-optimal FLAG-100% HIS, URA3\]**Oligonucleotides**DNA and RNA sequencesThis paperSee [Table S2](#mmc2){ref-type="supplementary-material"}**Recombinant DNA**pJC134This studyPGK1pG with stem loop at 5′ UTR (under control of GAL1 UAS)pJC672[@bib37]PGK1pG reporter with OPT ORF (under control of GAL1 UAS)pJC673[@bib37]PGK1pG reporter with NON-OPT ORF (under control of GAL1 UAS)pJC857[@bib38]0% optimal HIS3 with N-terminal FLAG tag (GAL1 promoter)pJC862[@bib38]50% optimal HIS3 with N-terminal FLAG tag (GAL1 promoter)pJC867[@bib38]100% optimal HIS3 with N-terminal FLAG tag (GAL1 promoter)pJC929This studypJC134 with SpeI before start codon and XhoI sites after stop codon of PGK1 ORFpJC930This studyPGK1pG reporter with stem loop at 5′ of OPT ORF (under control of GAL1 UAS)pJC931This studyPGK1pG reporter with stem loop at 5′ of NON-OPT ORF (under control of GAL1 UAS)LP_P24-1[@bib44]MultiBac expression vector for *S. pombe* Ccr4-NotLP_P24-2[@bib44]MultiBac expression vector for *S. pombe* Ccr4-Not (Ccr4 E387A)LP_P24-3[@bib44]MultiBac expression vector for *S. pombe* Ccr4-Not (Caf1 D53A)LP_P24-4[@bib44]MultiBac expression vector for *S. pombe* Ccr4-Not (Ccr4 E387A, Caf1 D53A)LP_P22-9This studypGEX6P-2 expression vector for *S. pombe* Ccr4(EEP) (res 331-621)LP_P24-5This studypET28a expression vector for *S. pombe* Caf1(FL) (res 1-335)LP_P22-10This studypGEX6P-2 expression vector for *S. pombe* Pab1(FL) (res1-653)LP_P22-11This studypGEX6P-2 expression vector for *S. pombe* Pab1 (res80-653)LP_P22-12This studypGEX6P-2 expression vector for *S. pombe* Pab1ΔC (res80-576)LP_P22-13This studypGEX6P-2 expression vector for *S. pombe* Pab1ΔPC (res80-441)LP_P22-14This studypGEX6P-2 expression vector for *S. pombe* Pab1(RRM1mut) (res80-653; Y83A)LP_P22-15This studypGEX6P-2 expression vector for *S. pombe* Pab1(RRM2mut) (res80-653; F171A)LP_P22-16This studypGEX6P-2 expression vector for *S. pombe* Pab1(RRM3mut) (res80-653; Y264A)LP_P22-17This studypGEX6P-2 expression vector for *S. pombe* Pab1(RRM4mut) (res80-653; F367A)**Software and Algorithms**ImageJNIH<https://imagej.nih.gov/ij/>GraphPad Prism 6GraphPad<https://www.graphpad.com/scientific-software/prism/>switchANALYSISDynamic Biosensors<https://www.dynamic-biosensors.com/software/>ImageQuantGE HealthcareTL 5.2Bowtie[@bib26]<http://bowtie-bio.sourceforge.net>Samtools[@bib28]<http://samtools.sourceforge.net/>Cufflinks[@bib48]<http://cole-trapnell-lab.github.io/cufflinks/cuffdiff/>R v.3.3.2The R Foundation for Statistical Computing<https://www.r-project.org/>RStudio Desktop v.1.1.383RStudio<https://www.rstudio.com/products/rstudio/>

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources should be directed to and will be fulfilled by the Lead Contact, Lori Passmore (<passmore@mrc-lmb.cam.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

Recombinant proteins Pab1, Ccr4 and Caf1 were expressed in *Escherichia coli* BL21 Star (DE3) cells grown in 2 × TY media. Recombinant Ccr4-Not and Caf1-Ccr4 were expressed in the *Spodoptera frugiperda Sf9* cell line. *Saccharomyces cerevisiae* strains used in this study are listed in the [Key Resources Table](#sec4.1){ref-type="sec"}. All yeast strains were grown at 24°C in synthetic media supplemented with the appropriate amino acids and either 2% glucose, 2% raffinose/1% sucrose or 2% galactose/1% sucrose. Yeast was harvested at mid-log phase (OD~600nm~ = 0.36--0.55).

Method Details {#sec4.4}
--------------

### Protein Purification {#sec4.4.1}

Intact Ccr4-Not complex was purified after overexpression of the seven core subunits of the *Schizosaccharomyces pombe* complex (Ccr4, Caf1, Not1, Not2, Not3, Not4/Mot2 and Rcd1/Caf40) in *Sf*9 cells ([@bib44]).

The Caf1-Ccr4 heterodimeric complex was prepared from the *Sf*9 lysate used for Ccr4-Not expression as these subunits were expressed in molar excess and were captured using the Strep II tag on the Caf1 subunit. This sample was separated from Ccr4-Not with a 5 mL HiTrap Q HP column (GE Healthcare) equilibrated in buffer A (20 mM HEPES pH 7.4, 50 mM NaCl, 0.1 mM TCEP) eluted over a 10-column volume gradient into buffer A with 1 M NaCl. The pooled eluate was applied to a Superdex 200 10/300 GL size-exclusion column (GE Healthcare) equilibrated in buffer A. Peak fractions were concentrated with an Amicon Ultra 50 kDa MWCO centrifugal concentrator (Millipore) and stored at −80°C.

For preparation of isolated nucleases, DNA encoding *S. pombe CAF1* and *CCR4* were synthesized with codon optimization (Genscript). Full-length *CAF1* was cloned into a modified pET28a plasmid for expression as an N-terminal hexahistidine fusion in BL21 Star (DE3) *E. coli* (Thermo Fisher Scientific). The sequence encoding the Ccr4 EEP domain (amino acids 331--621) was amplified using primers Ccr4_Nuc_Fwd and Ccr4_Nuc_Rev ([Table S2](#mmc2){ref-type="supplementary-material"}). This was cloned into pGEX-6P-2 plasmid using an In-Fusion HD Cloning Kit (Clontech) for overexpression as an N-terminal GST-fusion in *E. coli* BL21 Star (DE3) cells. Transformed cells were grown at 37°C to an A~600 nm~ of 0.6 before the temperature was reduced to 18°C and protein expression induced by the addition of IPTG to 1 mM (Caf1) or 0.5 mM (Ccr4 EEP). Growth was continued for 18 hr before cells were harvested by centrifugation and flash frozen for storage at −80°C.

Caf1-expressing cells were defrosted and lysed by sonication in lysis buffer (50 mM HEPES pH 8, 500 mM NaCl, 2 mM MgCl~2~, 1 mM TCEP) supplemented with protease inhibitor cocktail (Roche). Caf1 was purified from the lysate with Ni-NTA affinity resin (QIAGEN). The resin was washed with lysis buffer supplemented with 20 mM imidazole, and the protein eluted in buffer B (20 mM HEPES pH 8, 300 mM NaCl, 2 mM MgCl~2~, 0.5 mM TCEP and 250 mM imidazole). The hexahistidine tag was cleaved by treatment with 3C protease. The sample was diluted to 150 mM NaCl before application to a 5 mL HiTrap Q HP column and elution over a 10-column volume gradient into buffer B with 1 M NaCl. Peak fractions were pooled and applied to a HiLoad Superdex 75 26/60 pg column equilibrated in 20 mM HEPES pH 8, 150 mM NaCl, 2 mM MgCl~2~, 0.5 mM TCEP. The protein was concentrated with an Amicon Ultra 10 kDa MWCO concentrator (Millipore) and stored at −80°C.

Ccr4 EEP-expressing cells were sonicated in lysis buffer containing 50 mM Tris-HCl pH 8, 250 mM KCl, 1 mM TCEP, and protein was purified from the lysate with Glutathione Sepharose 4B (GE Healthcare). The resin was washed with buffer A containing 1 M NaCl, and protein was eluted in buffer A supplemented with 50 mM glutathione. Nucleic acid contaminants were removed by application of the sample to a 5 mL HiTrap Q HP column equilibrated in buffer A and eluted over a 10-column volume gradient into buffer A with 1 M NaCl. The sample was treated with 3C protease to cleave off the GST tag (16 hr at 4°C), and then applied to a 5 mL HiTrap Q HP column run in the conditions described above. The sample was then applied to a 5 mL HiTrap Heparin HP column equilibrated in buffer A and eluted over a 10-column volume gradient into buffer A with 1 M NaCl. Peak fractions were pooled and applied to a Superdex 200 10/300 GL size-exclusion column (GE Healthcare) equilibrated in buffer A. Pure protein was concentrated with an Amicon Ultra 10 kDa MWCO concentrator and stored at −80°C.

DNA encoding Pab1 amino acids 80--653 was amplified from *S. pombe* cDNA using primers Pab1_res80_Fwd and Pab1_Rev ([Table S2](#mmc2){ref-type="supplementary-material"}) and cloned into pGEX-6P-2 plasmid using an In-Fusion HD Cloning Kit (Clontech). DNA encoding variants Pab1ΔC and Pab1ΔPC were amplified from this vector with primers Pab1_res80_Fwd and Pab1ΔC_Rev or Pab1ΔPC_Rev. These were also cloned into pGEX-6P-2 plasmid. Pab1 was expressed and purified as described above for Ccr4 (EEP nuclease domain).

PCR-based site-directed mutagenesis was performed with a Quikchange Lightning Multi Mutagenesis Kit (Agilent) to generate mutations in Pab1 (RRM1mut: Y83A, RRM2mut: F171A, RRM3mut: Y264A, RRM4mut: F367A). A single primer was used to introduce each modification: Pab1_Mut1_QC, Pab1_Mut2_QC, Pab1_Mut3_QC, and Pab1_Mut4_QC ([Table S2](#mmc2){ref-type="supplementary-material"}). Pab1 variants were purified as described for wild-type versions.

### Deadenylation Assays {#sec4.4.2}

Deadenylation activity was measured ([@bib55]) in 20 mM PIPES pH 6.8, 10 mM KCl, 45 mM NaCl, 2 mM Mg(OAc)~2~, 0.1 mM TCEP (includes components added with protein factors) at 22°C. Ccr4-Not and Caf1-Ccr4 were prepared at 1 μM (10×) in 20 mM HEPES pH 7.4, 400 mM NaCl, 2 mM Mg(OAc)~2~, 0.1 mM TCEP and added to a final concentration of 100 nM in the reaction. Caf1 and Ccr4 (EEP domain) were prepared in the same buffer and added to final concentrations of 5 μM and 1 μM respectively. Pab1 was prepared in 20 mM HEPES pH 7.4, 50 mM NaCl, 0.1 mM TCEP and added to a final concentration of 200 nM or 400 nM in the reaction (for 1 or 2 Pab1 molecules per RNA respectively). Pab1 was incubated with RNA for 10 min at 22°C prior to the addition of enzyme to allow protein-RNA binding to reach equilibrium.

23-mer-A30, A30 and 20-mer-A10 RNAs ([Table S2](#mmc2){ref-type="supplementary-material"}) were synthesized with a 5′ 6-FAM fluorophore label (Integrated DNA Technologies). The 20-mer-A60 RNA was generated by *in vitro* transcription: A modified pUC57 vector containing a T7 promoter and the encoded RNA sequence was linearized with BsaI restriction enzyme to generate the DNA template ([@bib55]). *In vitro* transcription was performed using standard procedures ([@bib57]).

200 nM RNA was used in each reaction. Reactions were stopped at the indicated time points by addition of 2 × denaturing loading dye (95% formamide, 10 mM EDTA, 0.01% w/v bromophenol blue). Samples were applied to TBE (Tris-borate-EDTA)-polyacrylamide gels containing 7 M urea (20% acrylamide for 23-mer-A30, 20-mer-A10 and A30; 14% acrylamide for 20-mer-A60) and run at 400 V in 1 × TBE running buffer. Gels were scanned with a Typhoon FLA-7000 directly for 5′ 6-FAM labeled RNA (20-mer-A10, 23-mer-A30 and A30) or following staining of the gel with SYBR Green II for unlabeled RNA (20-mer-A60). Densitometric analysis was performed with ImageJ ([@bib42], [@bib55]). Poly(A) tail lengths were calibrated using RNA markers with no tail and tails of known length. Intermediate tail lengths were calculated by counting bands on gels with single-nucleotide resolution ([@bib55]). Average rates of deadenylation were calculated by linear regression of modal tail length plots. All results are representative of experiments performed in triplicate. The greatest source of error was determined to be in applying a linear fit and therefore we calculated the uncertainty in the average rate as the 95% confidence interval of the slope.

For the analysis of Pab1 dissociation during deadenylation, reactions were stopped by the addition of 2 × non-denaturing stop solution (20 mM Tris-HCl pH 8, 5 mM EDTA, 10% v/v glycerol, 0.1% Orange G). Samples were applied to 6% TBE-polyacrylamide non-denaturing gels and electrophoresis was performed at 100 V in 1 × TBE running buffer. Gels were scanned with a Typhoon FLA-7000.

### Electrophoretic Mobility Shift Assays {#sec4.4.3}

Binding reactions (10 μl) were prepared by adding Pab1 at the indicated molar excess (0.5 × = 100 nM, 1 × = 200 nM, 2 × = 400 nM, 3 × = 600 nM, 4 × = 800 nM) to RNA (200 nM) in 20 mM PIPES pH 6.8, 10 mM KCl, 90 mM NaCl, 2 mM Mg(OAc)~2~, 0.1 mM TCEP. The sample was incubated for 15 min at 22°C before the addition of 6 × loading dye (30% glycerol and 0.2% w/v orange G). Samples were applied to 6% TBE-polyacrylamide non-denaturing gels and electrophoresis was performed at 100 V in 1 × TBE running buffer. Gels were scanned with a Typhoon FLA-7000 directly for 5′ 6-FAM labeled RNA (20-mer-A10, 23-mer-A30 and A30) or following staining of the gel with SYBR Green II for unlabeled RNA (20-mer-A60).

### Fluorescence Polarization Assays {#sec4.4.4}

A two-fold protein dilution series was prepared in 20 mM HEPES pH 7.4, 150 mM NaCl. Proteins were incubated for 2 hr at 22°C with 0.2 nM 5′ 6-FAM RNA (synthesized by IDT, [Table S2](#mmc2){ref-type="supplementary-material"}). Fluorescence polarization was measured with a PHERAstar Plus microplate reader (BMG Labtech). Dissociation constants were estimated by non-linear regression with a one-site binding curve in *GraphPad Prism 6*. Error bars indicate the standard deviation in five replicate measurements.

### SwitchSENSE Kinetic Analysis {#sec4.4.5}

Kinetic measurements were performed using a DRX series instrument with a MPC-48-2-Y1 chip (Dynamic Biosensors). Hybrid oligonucleotides were synthesized (IDT) with the RNA of interest (A30, or N20A~n~, [Table S2](#mmc2){ref-type="supplementary-material"}) at the 5′ end followed by single-stranded DNA complementary in sequence to the fluorescently labeled oligonucleotide on the chip. Annealing was performed by flowing 500 nM oligonucleotide over the chip for 4 min in a buffer of 20 mM HEPES pH 7.4, 40 mM NaCl and 0.001% Tween-20. Analysis of Pab1 kinetics was performed by application of 25 nM Pab1 in a buffer of 20 mM HEPES pH 7.4, 150 mM NaCl and 0.001% Tween-20. Binding experiments were performed at 20°C with a flow rate of 30 μl/min. The dynamic response represents the change in nanolever switch speed on the timescale 0--4 μsec ([@bib25]). Data points from dissociation experiments 20-mer-A10, 20-mer-A15 and A30 were averaged in 10 s intervals to improve the signal-to-noise. Kinetic constants were estimated by fitting of an exponential function with GraphPad Prism 6.

### Yeast Strains and Growth Conditions {#sec4.4.6}

Yeast strains used in this study are listed in the [Key Resources Table](#sec4.1){ref-type="sec"}. All strains were grown at 24°C in synthetic media supplemented with the appropriate amino acids and either 2% glucose, 2% raffinose/1% sucrose or 2% galactose/1% sucrose. Cells were harvested at mid-log phase (OD~600nm~ = 0.36--0.55).

### RNA Labeling and RNase A/T1 Digestion {#sec4.4.7}

Yeast (*rpb1-1*, *rpb1-1 ccr4*Δ, and *rpb1-1 caf1*Δ) were grown to mid-log phase in minimal synthetic media (pH 6.5). At mid-log phase, transcription was repressed by shifting cells to 37°C, and cell aliquots were harvested at 0, 3, 6, 8, 10, 15, 20, 30, 45, 60 min. Total RNA was isolated from each sample as described previously ([@bib19]).

\[5′ ^32^P\] cytidine 3′ 5′ bisphosphate (pCp) was prepared by combining 1 μL 833 μM 3′ CMP, 33 μL 25 μM \[γ^32^P\] ATP (Perkin Elmer NEG035C), 4 μL 10 × OptiKinase buffer, and 2 μL OptiKinase (USB 78334Y) and incubating for 1 hr at 37°C before heat inactivating at 65°C for 10 min. 2 μg of each total RNA sample isolated above was then \[5′ ^32^P\] pCp labeled at 4°C overnight after combining the RNA with 2 μL \[5′ ^32^P\] pCp in a 10 μL reaction containing 1 × T4 RNA ligase buffer, 10% DMSO, 0.5 mM rATP, and 10 units T4 RNA ligase (Thermo Fisher Scientific EL0021). Samples were purified by passing through two 1 mL G50 Sephadex columns after adding 90 μL of HS buffer (20 mM Tris-HCl pH 7.5, 10 mM EDTA and 300 mM NaCl).

Next, 25 μL of each pCp-labeled RNA sample was RNase A and RNase T~1~ digested at 30°C for 30 min in 1 × RNase A/T~1~ digestion buffer \[20 mM Tris-HCl pH 7.5, 1 mM MgCl~2~, 100 mM KCl, and 1 mg/ml tRNA (Sigma R4251)\] using 1 unit RNase T~1~ (Sigma R1003) and 10 μg RNase A (Sigma R6513) in a 100 μL reaction. The samples were extracted with phenol/chloroform buffered with LET (25 mM Tris-HCl, pH 8.0, 100 mM LiCl, 20 mM EDTA, pH 8.0) and then ethanol precipitated with ammonium acetate in the presence of 1 μL GlycoBlue (Thermo Fisher Scientific AM9515). The precipitated RNA was run on denaturing 12% polyacrylamide sequencing gels and dried before exposing to a phosphorimager screen.

### Reporter Construction {#sec4.4.8}

The plasmids and oligonucleotides used in this study are listed in the [Key Resources Table](#sec4.1){ref-type="sec"} and [Table S2](#mmc2){ref-type="supplementary-material"}. To construct the synthetic reporters containing the stem-loop at the 5′ UTR of OPT (pJC672) and NON-OPT (pJC673) reporters, SpeI and XhoI sites were introduced directly before the start codon and after the stop codon of the *PGK1* ORF in pJC134 (SL-PGK1pG) by oJC3208/3209 and oJC2379/2380, respectively to create pJC929. The OPT and NON-OPT ORFs were subsequently cloned into this plasmid by using SpeI and XhoI sites to generate pJC930 (SL-OPT) and pJC931 (SL-NON-OPT), respectively.

### Transcriptional Shut-Off and Pulse-Chase {#sec4.4.9}

For the *GAL1* promoter shut-off experiment, cells were grown at 24°C in synthetic media with 2% galactose/1% sucrose to allow for expression of the reporters. Cells were shifted to synthetic media without sugar at an OD~600nm~ = 0.4, and then transcription was repressed by adding glucose to a final concentration of 4%. Aliquots were collected at the time points indicated in the figures.

For the *GAL1* promoter pulse-chase experiments, cells were inoculated in synthetic media containing 2% raffinose/1% sucrose to keep the *GAL1* promoter off. Once cells reached to OD~600nm~ = 0.36, they were shifted to synthetic media without sugar and the transcription of *GAL1* promoter was activated by adding 2% galactose for 8 min. After an 8-min induction of transcription, for WT and *dhh1*Δ strains ([Figure 5](#fig5){ref-type="fig"}B), cells were shifted to synthetic media without sugar and then transcription was repressed by adding glucose to a final concentration of 4%; for *rpb1-1*, *rpb1-1/caf1*Δ and *rpb1-1/ccr4*Δ strains ([Figure 6](#fig6){ref-type="fig"}B), transcription was repressed by adding glucose to a final concentration of 4% and shifting cells to 37°C. Cells were collected after transcriptional inhibition at the time points indicated in the figures.

Total RNA was extracted by phenol/chloroform/LET (25 mM Tris, pH 8.0, 100 mM LiCl, 20 mM EDTA) and precipitated by 95% EtOH. 30-40 μg of RNA was separated on 1.4% agarose-formaldehyde gels at 100 V for 1.5 hr or 6% high resolution polyacrylamide gels at 400 V for 14.5 hr, transferred to nylon membranes and probed with ^32^P-labeled antisense oligonucleotides complementary to poly(G) (oJC168), *HIS3* (oJC2564), and *SCR1* (oJC306). Blots were exposed to PhosphorImager screens, scanned by Typhon 9400, and quantified by ImageQuant software to determine half-lives. Quantification of mRNA half-life ([Figures 6](#fig6){ref-type="fig"}A and 6C) was performed following normalization to *SCR1* RNA, which is not shown. The deadenylation rates of OPT and NON-OPT mRNAs ([Figures 5](#fig5){ref-type="fig"}B and [6](#fig6){ref-type="fig"}B) were determined by calculating changes of shortest poly(A) tail lengths in time points which have more than A10 on blots in [Figures 5](#fig5){ref-type="fig"}B and [S7](#mmc1){ref-type="supplementary-material"}.

### Global mRNA Half-Life Analysis {#sec4.4.10}

RNA-seq experiment and half-lives analysis were performed as described in [@bib37]. Briefly, *rpb1-1* and *rpb1-1/caf1*Δ cells were grown to mid-log phase at 24°C and shifted to a non-permissive temperature (37°C) to inactivate RNA polymerase II. Cells were collected at various time points after the inhibition of transcription. RNA was extracted and 1 ng of ERCC Phage NIST spike-ins was added. Libraries were prepared by using Illumina TruSeq Stranded Total RNA and mRNA library prep kits, quantified by an Agilent Bioanalyzer and sequenced by using paired-end 100 bp reads with an index read on Illumina HiSeq2000. Sequencing data are available at Gene Expression Omnibus (<https://www.ncbi.nlm.nih.gov/geo>) with accession number [GSE114560](ncbi-geo:GSE114560){#intref0065}.

Reads were aligned to the SacCer2 *S. cerevisiae* reference genome by Bowtie v0.12.7 ([@bib26]) and the aligned reads were further converted into bam format and indexed by Samtools v0.1.18 ([@bib28]). Gene FPKM values were calculated by Cufflinks v1.3.0 ([@bib48]) and annotated to the SacCer2 SGD gene annotation downloaded from the UCSC browser. The raw FPKM values were normalized to the spike-ins reads.

The expression levels of each gene at each time point were normalized to the initial expression level (0-min time point). The half-life for each gene was determined by fitting data into an exponential decay curve. Dubious and unverified ORFs, genes for which the average absolute residual was greater than 0.14, and genes with an estimated half-life longer than the measured time course were excluded. Each transcript's average optimality was calculated using the definitions of codon optimality in [@bib36], then boxplots of mRNA half-lives in *caf1*Δ cells relative to wild-type cells for each optimality bin were generated using ggplot2 / geom_boxplot in R. Base R functions were used to perform ANOVA (p = 1.05x10^--14^), then Tukey's Honest Significant Difference test for pairwise comparisons with the \< 40% optimality bin ([Figure 6](#fig6){ref-type="fig"}D).

### Analysis of Pab1 Occupancy {#sec4.4.11}

Pab1 binding per nucleotide of poly(A) tail for each *S. cerevisiae* transcript was calculated as follows. First, we converted "logFC" values in "13059_2014_559_MOESM2_ESM.xlsx" ([@bib15]) to fold-change, then divided these values by mean poly(A) tail lengths derived from "GSE52809_Cerevisiae_total.txt" ([@bib45]). Next, each transcript's average optimality was calculated using the definitions of codon optimality in [@bib36], then boxplots of Pab1 binding per nucleotide of poly(A) tail for each optimality bin were generated using ggplot2 / geom_boxplot in R. Base R functions were used to perform ANOVA (p \< 2x10^−16^), then Tukey's Honest Significant Difference test for pairwise comparisons with the \< 40% optimality bin ([Figure 5](#fig5){ref-type="fig"}A).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Statistical parameters are reported in the Figures and Figure Legends.

### *In Vitro* Deadenylation Analysis {#sec4.5.1}

All results of *in vitro* deadenylation analysis are representative of experiments performed in triplicate. Average rates of deadenylation were calculated by linear regression of modal tail length plots. Uncertainty is presented as the 95% confidence interval of the linear fit slope as this is the largest source of error.

### Fluorescence Polarization Assays {#sec4.5.2}

Quantification of interaction affinity was determined by non-linear regression with a one-site binding curve. Error bars indicate the standard deviation in replicate measurements and K~D~ measurements are presented as the mean ± standard error.

### SwitchSENSE Kinetic Analysis {#sec4.5.3}

Analysis of Pab1 dissociation rate was performed in triplicate for each RNA sequence and representative sensograms are shown. Rate constants and half-lives for dissociation are presented as the mean ± standard error. Analysis of Pab1 association rate was performed in triplicate for each protein concentration. Linear regression was used to determine the kinetic constant for association (*k*~*on*~), which is presented as the mean ± standard error.

### *In Vivo* Deadenylation Analysis {#sec4.5.4}

Rates of *in vivo* deadenylation were analyzed by quantifying the shortest poly(A) tail lengths at each time point. In [Figure 6](#fig6){ref-type="fig"}B, error bars indicate standard deviation in triplicate measurements.

### *In Vivo* mRNA Half-Life Analysis {#sec4.5.5}

Reporter mRNA half-lives were calculated by densitometry with normalization to *SCR1* RNA control and are presented as the mean ± standard deviation. For transcriptome-wide analysis of mRNA half-lives, the expression levels of each gene at each time point were normalized to the initial expression level (0-min time point). The half-life for each gene was determined by fitting data into an exponential decay curve. Boxplots of mRNA half-lives in *caf1*Δ cells relative to wild-type cells for each optimality bin were generated using ggplot2 / geom_boxplot in R. Base R functions were used to perform ANOVA (p = 1.05x10^--14^), then Tukey's Honest Significant Difference test for pairwise comparisons with the \< 40% optimality bin.

### Pab1 Enrichment {#sec4.5.6}

Boxplots of Pab1 binding per nucleotide of poly(A) tail for each optimality bin were generated using ggplot2 / geom_boxplot in R. Base R functions were used to perform ANOVA (p \< 2x10^--16^), then Tukey's Honest Significant Difference test for pairwise comparisons with the \< 40% optimality bin ([Figure 5](#fig5){ref-type="fig"}A).

Data and Software Availability {#sec4.6}
------------------------------

The accession number for the raw RNA sequencing data files used for the calculation of global mRNA half-lives is NCBI GEO: [GSE114560](ncbi-geo:GSE114560){#intref0070}.
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